Project Grant R01HL173483
Award Date
8/15/24
Completion Date
5/31/29
Dollars Obligated
$427K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Iowa City, IA 52242, USA
Similar Awards
This $1,420,164 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to simultaneously evaluate changes in cerebral oxygen metabolism and upper airway anatomy in obstructive sleep apnea (OSA) patients. The key objectives are to: 1) optimize a time-resolved MRI protocol and synchronized airway plethysmography to detect metabolic and structural changes during induced apneas; 2)...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $615,621 to Powell Mansfield, Inc. to develop and validate a diagnostic tool for obstructive sleep apnea (OSA) called deep learning-enhanced transmembranous electromyography (DL-TMEMG).
The project aims to establish the feasibility of TMEMG to accurately diagnose OSA patients, optimize the deep learning algorithm, and then demonstrate...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) is for the development and use of a novel wearable sensor system called "Sleeptronix" to assess sleep, temperature, and cortisol levels in individuals with obstructive sleep apnea (OSA). The $253,500 award will be used to refine the Sleeptronix system and evaluate its ability to accurately measure clinically-used metrics like...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) totaling $745,121 will support research at the University of Missouri System investigating the relationship between obstructive sleep apnea (OSA) and cardiovascular dysfunction. The research aims to elucidate the physiological and molecular mechanisms by which OSA-induced cellular senescence leads to vascular dysfunction, and to evaluate whether selectively...
This is a federal Project Grant award worth $466,500 from the National Heart, Lung and Blood Institute (NHLBI), funded under the Cardiovascular Diseases Research program (CFDA 93.837). The grant aims to develop a novel diagnostic pipeline that uses computer vision algorithms and computational fluid dynamics to quantify airway stenosis morphology and respiratory effort in pediatric patients with subglottic stenosis. The pipeline will leverage standard clinical endoscopy data to generate 3D...
This $128,047 Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports the development of an innovative urine-based diagnostic test for obstructive sleep apnea (OSA). The grant recipient, PGXL Technologies LLC, is collaborating with the University of Louisville Research Foundation to create a urine collection kit and validate a multiplex immunoassay panel using four protein biomarkers to detect...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $250,931 to support the development and validation of a novel diagnostic modality for upper airway obstruction (UAO). The research aims to integrate dynamic computed tomography (4D-CT) imaging with computational fluid dynamics (CFD) analysis to create a quantitative, patient-specific assessment of UAO severity....
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $711,226 to the University of California, Los Angeles (UCLA) to investigate the relationship between obstructive sleep apnea (OSA) and brain changes.
The research aims to examine regional brain temperatures, metabolites, and antioxidant levels in OSA patients compared to healthy controls, as well as assess whether continuous...
This $1,415,112 Project Grant, awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), aims to evaluate a telehealth-delivered adaptive intervention to promote continuous positive airway pressure (CPAP) therapy adherence and improve health outcomes for adults newly diagnosed with obstructive sleep apnea (OSA). The key objectives are to: 1) compare the effects of motivational enhancement, device support, and standard...
This $421,800 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) Cardiovascular Diseases Research program (CFDA 93.837) supports research to investigate the effects of Chronic Intermittent Hypoxia (CIH) on cholinergic modulation at hypoglossal motoneurons. The project, titled "Effects of Chronic Intermittent Hypoxia on Cholinergic Modulation at Hypoglossal Motoneurons", seeks to evaluate neuroanatomical and functional changes in cholinergic signaling at...